United Kingdom · Question · Written question
UIN 37512
Semaglutide
Original
Introduced
11 March 2025
Last action
18 March 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
18 March 2025
Summary
To ask the Secretary of State for Health and Social Care, what the total cost to the public purse was of prescribing Ozempic to NHS patients without a diagnosis of diabetes, heart disease or kidney disease in 2024-25.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 March 2025
Written question
To ask the Secretary of State for Health and Social Care, what the total cost to the public purse was of prescribing Ozempic to NHS patients without a diagnosis of diabetes, heart disease or kidney disease in 2024-25.
Source: Commons
18 March 2025
Answer
Information is not collected on the clinical condition a medicine is prescribed for. Ozempic is only licenced for the treatment of type 2 diabetes and guidance is clear that medications licensed to treat type 2 diabetes should not be prescribed for weight...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-03-11/37512
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1783537
- uk · wq-1783537 · source updated 18 March 2025